文摘
BackgroundCervical cancer can be subdivided into stages I–IV according to the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) classification. According to the literature local clinical staging shows an error rate of 17–32 % in patients with early stage (FIGO 1B) cervical cancer and up to 65 % in advanced stages of cervical cancer (FIGO III–IV) and consequently has a negative influence on the prognosis. According to the guidelines of the German Society of Gynecology and Obstetrics (DGGG), the working group on gynecological oncology (AGO) and the German Cancer Society (DKG) the use of modern cross-sectional imaging diagnostics, such as magnetic resonance imaging (MRI) and computed tomography (CT) for staging is recommended for the first time. The MRI investigation of the pelvis is recommended for pretherapeutic staging from stage IB2 onwards. Because of its high soft tissue contrast, MRI allows excellent non-invasive local staging of cervical cancer with direct demonstration of tumors as well as assessment of the prognosis based on morphological imaging features.